Compare HCM & TMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCM | TMC |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | Hong Kong | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | N/A | N/A |
| Metric | HCM | TMC |
|---|---|---|
| Price | $14.13 | $7.80 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $13.75 | $6.94 |
| AVG Volume (30 Days) | 29.0K | ★ 9.2M |
| Earning Date | 08-07-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $602,197,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.54 | N/A |
| P/E Ratio | $5.26 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.51 | $0.72 |
| 52 Week High | $19.50 | $11.35 |
| Indicator | HCM | TMC |
|---|---|---|
| Relative Strength Index (RSI) | 37.46 | 63.96 |
| Support Level | $14.11 | $6.26 |
| Resistance Level | $14.63 | $7.07 |
| Average True Range (ATR) | 0.27 | 0.55 |
| MACD | -0.01 | 0.34 |
| Stochastic Oscillator | 21.69 | 89.19 |
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.